Form 4: Aclarion Executive Chairman Receives RSU Grant

Aclarion, Inc. Executive Chairman Jeffrey John Thramann was granted 100,000 restricted stock units vesting in 2027.

Summary

• Executive Chairman Jeffrey John Thramann received a grant of 100,000 restricted stock units (RSUs).
• The grant was issued on June 11, 2026, under the company's equity incentive plan.
• Each RSU represents a contingent right to receive one share of Aclarion common stock.
• The RSUs are scheduled to vest 100% on June 1, 2027.
• The grant includes an acceleration clause for full vesting upon a change of control.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation that does not signal immediate operational changes.

Positives

• Alignment of executive interests with long-term shareholder value through equity-based compensation.
• Retention of key leadership through a multi-year vesting schedule.

Negatives

• Potential for future shareholder dilution upon the vesting and issuance of the underlying common stock.

Risks

• Dilution risk for existing shareholders upon the conversion of RSUs into common stock.
• Dependence on company performance and retention of the Executive Chairman to realize the value of the equity incentive.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on executive compensation.

Management Comments

• The grant is subject to the terms of the Company's equity incentive plan, including full vesting upon a change of control.

Industry Context

StockSavvy.ai notes that equity grants to executive leadership are standard corporate governance practices intended to incentivize long-term strategic focus and retention in the healthcare technology sector.

Comparison to Industry Standards

• The use of RSU grants with multi-year vesting is consistent with standard executive compensation packages for small-cap technology and healthcare firms.
• Acceleration clauses upon change of control are common market practice to protect executive interests during M&A activity.

Corporate Governance

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual vesting and issuance of shares.

Next Steps

• Vesting of the 100,000 RSUs on June 1, 2027.

Key Dates

Keywords

Aclarion, ACON, Form 4, Insider Trading, Equity Incentive, Restricted Stock Units